No Data
No Data
Guardant Health's Shield Blood Test Now Covered for VA Community Care Beneficiaries
Guardant Health's CIO Makes a Strategic Stock Sale
Insider Sale: Chief Information Officer of $GH Sells 3,500 Shares
BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $60
Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating, Announces Target Price $56
BTIG Keeps Their Buy Rating on Guardant Health (GH)